Cell Expansion Market

SKU: DMPH2695 | Last Updated On: Sep 16 2022 | Available Formats

> Cell Expansion Market Expected to reach a high CAGR of 18.65% during the forecast period 2022-2029

The cell Expansion Market is segmented By Product Type (Automated Cell Expansion Systems, Instruments, Consumables, Bioreactors), By Cell Type (Animal Cells, Human Cells, Others), By Application (Regenerative Medicine and Stem Cell Research, Cancer & Cell-Based Research, Clinical Studies, Vaccine Production, Others), By End-User (Biopharmaceutical & Biotechnology Companies, Research Institutes, Cell Banks, Hospitals, Diagnostic Laboratories, Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Global Industry Size, Share, Outlook, and Opportunity Analysis, 2022-2029

 

Market Overview

[195 Pages Report] Cell Expansion Market size is projected to reach USD million by 2029, with growth at a CAGR of 18.65% during the forecast period (2022-2029).

Cell expansion is widely adopted to improve transplantation and for the treatment of several diseases such as cancer, diabetes, rheumatoid arthritis, and others. The cell expansion market growth is driven by several factors such as the rising incidence of chronic diseases, increasing government investments for cell-based research, the rising focus on personalized medicine, and GMP certifications for cell therapy production facilities.

As per DataM Intelligence, the research report covers detailed insights on the cell expansion market size, trends, share, growth, volume, demand, and competitive analysis in the major regions and countries such as North America (United States, Canada), European Countries (Germany, Italy, UK, Spain, France, Russia), Latin America (Mexico, Argentina), Asia Pacific (China, India, Japan, South Korea), and the Middle East and Africa region (Saudi Arabia, UAE, Qatar, and South Africa).

According to the study, by region, the North American cell expansion market is controlling the global market in terms of revenue share during the forecast period. Whereas the Europe market has gained the second position in terms of revenue generation the global next to the North America region, owing to numerous growing markets related to an increasing percentage of diseases, and growing research and developments on cell expansion which is helpful to the chronic diseases.

Cell Expansion Market Scope

Metrics

Details

Market CAGR

18.65%

Segments Covered

By Product Type, By Cell Type, By Application, By End User, and By Region

Report Insights Covered

Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights.

Fastest Growing Region

Asia Pacific

Largest Market Share 

North America

To know more insights into the Market, Get Our Sample Brochure

Growth Dynamics:

Rising Incidence of Chronic Diseases is Driving the Cell Expansion Market Growth

Cell expansion is widely used for the research & development of drugs for the treatment of several diseases. This process is used in the production of vaccines, drugs, therapeutics, and antibiotics. The increasing incidence of diseases such as diabetes and cancer has led to rising demand for extensive research to develop new treatment options.

As per the International Diabetes Federation, diabetes patients spent US$ 760 billion in 2019, most of which, most was spent by Type-1 diabetes patients on insulin drugs. Around 463 million adults (20-79 years) are living with diabetes currently, and by 2045 this is projected to rise to 700 million. The proportion of type 2 diabetes people is increasing in most countries. Also, as per the American Heart Association, in 2015, approximately 41.5% of the U.S. population was suffering from some form of cardiac disease, it is further estimated that this prevalence is likely to increase to 45% by 2035.

According to the Centers for Disease Control and Prevention (CDC) of the U.S., about half of the population (47%) of the United States have at least one of these three risk factors.

According to the National Cancer Institute, the most common cancers are prostate cancer, breast cancer, lung and bronchus cancer, colon and rectum cancer, melanoma of the skin, bladder cancer, non-Hodgkin lymphoma, kidney and renal pelvis cancer, endometrial cancer, leukemia, pancreatic cancer, thyroid cancer, and liver cancer. 

According to the National Cancer Institute, about 57% of new cancer cases in 2012 occurred in developing regions of the world which include Central America and parts of Africa and Asia; about 65% of cancer deaths also occurred in these regions. Hence, the growth in the prevalence of these diseases has resulted in a need to conduct extensive research for their diagnosis and treatment.

Segmentation Analysis:

By product type, the cell expansion market is segmented into consumables, instruments, automated cell expansion systems, bioreactors, and others. Among these, the consumables segment held the largest market share in 2019 due to the rising production of vaccines and other biologics in the biopharmaceutical and biotechnology industries. There is also a rising demand for new reagents among end-users that helps in market growth. The consumables segment is further segmented into reagents, media, sera, and disposables. Furthermore, owing to the COVID-19 outbreak, the market for cell expansion consumables is expected to grow further over the coming years.

By application, the cell expansion market is classified into regenerative medicine & stem cell research, cancer & cell-based research, clinical studies, vaccine production, and others. Among these, the regenerative medicine and stem cell research segment accounted for the largest market share in 2019 owing to the growing research funding for regenerative medicine and stem cell research by the government and various organizations.

By cell type, the cell expansion market is segmented into human cells and animal cells. Among these, human cells accounted for the largest market share in 2019. The human cell is further segmented into stem cells and differentiated cells. The adult cells segment includes Induced Pluripotent Stem Cells, Embryonic Stem Cells, and Differentiated Cells.

Based on region, North America is dominating the global cell expansion market over the forecast period due to the increasing incidence of cancer, growing government funding, increasing research activities on stem cell therapies, and raising awareness of advanced treatment methods.

COVID-19 Impact Analysis:

The COVID-19 pandemic continues to unfold every day with a severe impact on people, communities, and businesses. The growth in several industries is impacted significantly while numerous other markets may remain unscathed and show promising growth opportunities.

Increasing research and development are being undertaken by several pharmaceutical and biotechnology companies. Thus, rising demand for clinical research is expected to generate several opportunities for cell expansion equipment manufacturers, hence, is expected to boost the market growth over the forecast period.

The dramatic explosion of the novel coronavirus is affecting lives globally. Hospitals and labs need access to reliable COVID-19 test kits, and several companies are coming up to support the medical professionals on the front lines working to prevent the spread of COVID-19. As per the WHO ICTRP and the NIH ClinicalTrials.gov databases, about 27 clinical investigations of MSC-based cell therapy approaches have begun in China since the onset of the COVID-19 outbreak, as well as a growing number of academic and industry trials elsewhere.

Regenerative medicine & stem cell research is one of the major applications of cell expansion. Also, several cell expansion accessories and equipment such as cell culture media, and bioreactors, among others are being used in COVID-19 research. Therefore, the outbreak of COVID-19 is expected to impact the market positively.

Competitive Landscape:

The global market is fragmented with the presence of a large number of market players. Some of the major players contributing to the growth of the cell expansion industry are Thermo Fisher Scientific, Inc., Merck KGaA, Becton, Dickinson and Company, GE Healthcare, Terumo BCT, Beckman Coulter Inc. (a subsidiary of Danaher Corporation), Miltenyi Biotec, Stemcell Technologies, Inc., Takara Bio Inc., Lonza Group LTD., among others. The key players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the global cell expansion market.

For instance,

  1. In 2020, Eppendorf Group is expanding its production capacity at its Oldenburg, Holstein site in Germany. With the growing demand for consumables for COVID-19 research, the company will be manufacturing consumables made of high-quality plastic, such as pipette tips and tubes and single-use bioreactor vessels, at the newly expanded site.
  2. In 2020, Danaher has acquired the Biopharma business from General Electric Company's Life Sciences division which will be known as Cytiva and act as a standalone operating company within Danaher's Life Sciences segment.
  3. In 2020, Applikon Biotechnology has partnered with Sotelab to strengthen its presence in the advanced cultivation systems market in South America.
  4. In 2019, Thermo Fisher Scientific invested around US$ 24 million in the Scotland site to expand global bio-production capabilities with additional large-volume liquid manufacturing capacity for cell culture media to meet growing customer demand.

Trending Topics

Virtual Clinical Trials Market

Medical Device Testing Services Market

Oncology Information Systems Market

FAQ

What is the Growth Rate of the Cell Expansion Market?

growth at a CAGR of 18.65% during the forecast period (2022-2029).

What Companies Are Included in the Cell Expansion Market?

The firms include GE Healthcare, Terumo BCT, Stemcell Technologies, Inc., Miltenyi Biotec, Merck KGaA, Becton Dickinson and Company, and Lonza Group LIMITED.

What is The COVID-19 Impact on the Cell Expansion Market? 

The coronavirus affects the lives of millions worldwide. Hospital wards and labs need access to reliable COVID- 19 evaluation kits, as well as some companies, are returning up to support the experts on the front lines doing work to steer clear of the spread of COVID- 19. Based on the WHO ICTRP and the NIH clinical trials. Since the oncoming of the COVID-19 herpes outbreak, about 27 clinical investigations from MSC- based cell strategies have begun in China.

Did not find what you were looking for?Every 7 out of 10 customers request tailored reports. Get yours today!
We collate your requirements.
Our global research team is put into action.
We deliver, and make sure your endeavour is a success!

Buy This Report



Note*: For "Bundle/Bulk" Subscription of Reports,
please contact: [email protected]

Get your free sample proposal with a single click!

linkedinpinterest